Key result
Rare homozygous STX3 mutation linked to microvillus inclusion disease and neurologic findings in an infant.
Why the study?
Other clinical manifestations and associations with novel mutations in microvillus inclusion disease beyond myosin Vb gene mutations are lacking.
Case Report (n=1)
This case highlights the importance of considering Microvillus Inclusion Disease in neonates presenting with abnormal stools, metabolic acidosis, and neurological symptoms, expanding the clinical phenotype of STX3 mutations.
May prompt genetic testing for MVID in neonates with atypical feeding issues; leaves open broader MYO5B phenotype correlations.
BACKGROUND: Microvillus Inclusion Disease (MVID) was first described in the literature in 1978 with presentation of severe watery diarrhea, failure to thrive, and metabolic acidosis. Mutations in the myosin Vb (MYO5B) gene have been identified as causative for MVID, but other clinical manifestations and associations with novel mutations are lacking. METHODS: We report a full-term infant admitted to the neonatal intensive care unit (NICU) with abdominal distension and inability to sustain full enteral feeds. A retrospective chart review and review of the literature was performed. RESULTS: An infant with abnormal, mucoid-like stringy stools was incidentally found to have severe metabolic acidosis on routine lab monitoring. Acidosis corrected with total parenteral nutrition (TPN), but the infant experienced recurrent episodes of acidosis with enteral feeds. He was also noted to have abnormal ocular movements, fluctuating tonicity, and staring spells. He underwent an extensive workup and the diagnosis of microvillus inclusion disease was made by findings on electron microscopy. The diagnosis was confirmed with whole exome sequencing, showing a rare homozygous mutation in the syntaxin 3 (STX3) gene. This is the fifth reported patient with microvillus inclusion disease with a mutation in this gene, and the first with abnormal neurologic findings. CONCLUSION: It is important to consider MVID in the differential diagnosis of a neonate or infant with abnormal stools, metabolic acidosis, with and without neurologic symptoms for prompt referral and treatment.
No takes yet. Share an insight, caveat, or question.
Julia et al. (2019) conducted a case report in Microvillus Inclusion Disease (n=1). Syntaxin 3 (STX3) gene mutation was evaluated on Clinical presentation and genetic diagnosis. A rare homozygous mutation in the syntaxin 3 (STX3) gene was identified in a full-term infant presenting with microvillus inclusion disease, abnormal stools, metabolic acidosis, and neurologic findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: